Bluepharma, a Portuguese pharmaceutical company, has opened an industrial unit specialising in the production of oral solid high-potent drugs, namely in the oncology area.
As CARBOGEN AMCIS opens its doors to a new sterile liquid drug product manufacturing facility in France, EPM caught up with Pascal Villemagne, CEO of CARBOGEN AMCIS, to discuss what this will mean for CARBOGEN's capabilities in freeze-dried products.
Emma Palmer Foster, director of Discovery Park Ventures, shares her advice to early stage life sciences companies on how to improve their chances of gaining funding.
Bomi Group, a UPS Healthcare company, opened its new storage and distribution facility in Madrid following an 18-million-euro investment. This new logistics centre will be one of the largest warehouses in the European pharmaceutical sector.
Mayer Schrieber, CEO of Discovery Park, looks at the current situation of Life Sciences and forecasts what steps need to be taken in 2023 to move the sector forward.
Co-founded by the cancer institute Gustave Roussy, Paris-Saclay University and the French company Clevexel Pharma, Graegis Pharmaceuticals plans to start proof-of-concept clinical trials in 2023 in the prevention of radiation-induced dermatitis.
GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research, NUS, NTU Singapore and SITT to boost Singapore's biologics manufacturing capabilities.
EPM asks Sandra Hernandez, Global Clinical Flow Marketing Manager, Beckman Coulter Life Sciences, about her journey into the field of medical technology, what it's like being a woman in STEM, and some of the biggest challenges in the industry.
Martino Picardo, chairman of Discovery Park and a director of Discovery Park Ventures, explores the funding barriers preventing the growth of female-led life sciences companies.
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology.
Following the success of its laboratory for process development in India, ACG, is now also committed to launching a sister process lab in Mulheium, Germany in 2023.
